# Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

> **NCT00754403** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 312 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone and metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00754403
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2010-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754403, "Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00754403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*